Ashley Cordova, Chief Financial Officer at NovoCure Ltd (NVCR), sold 883 shares at $21.82 ($19K) on 2023-09-01, disclosed to the SEC on 2023-09-05.
Seasonal sale ($19k) by Chief Financial Officer — this insider has traded NVCR in September in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NVCR | SELL | 2025-03-03 | $452K | — | Filing → |
| NVCR | SELL | 2024-08-05 | $14K | — | Filing → |
| NVCR | SELL | 2023-08-04 | $35K | — | Filing → |